192 related articles for article (PubMed ID: 32591547)
1. The importance of the AMPK gamma 1 subunit in metformin suppression of liver glucose production.
An H; Wang Y; Qin C; Li M; Maheshwari A; He L
Sci Rep; 2020 Jun; 10(1):10482. PubMed ID: 32591547
[TBL] [Abstract][Full Text] [Related]
2. Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex.
Meng S; Cao J; He Q; Xiong L; Chang E; Radovick S; Wondisford FE; He L
J Biol Chem; 2015 Feb; 290(6):3793-802. PubMed ID: 25538235
[TBL] [Abstract][Full Text] [Related]
3. Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK.
Wang Y; An H; Liu T; Qin C; Sesaki H; Guo S; Radovick S; Hussain M; Maheshwari A; Wondisford FE; O'Rourke B; He L
Cell Rep; 2019 Nov; 29(6):1511-1523.e5. PubMed ID: 31693892
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
5. Role of AMP-activated protein kinase in mechanism of metformin action.
Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
[TBL] [Abstract][Full Text] [Related]
6. Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production.
He L; Chang E; Peng J; An H; McMillin SM; Radovick S; Stratakis CA; Wondisford FE
J Biol Chem; 2016 May; 291(20):10562-70. PubMed ID: 27002150
[TBL] [Abstract][Full Text] [Related]
7. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status.
Stephenne X; Foretz M; Taleux N; van der Zon GC; Sokal E; Hue L; Viollet B; Guigas B
Diabetologia; 2011 Dec; 54(12):3101-10. PubMed ID: 21947382
[TBL] [Abstract][Full Text] [Related]
8. Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis.
Olivier S; Pochard C; Diounou H; Castillo V; Divoux J; Alcantara J; Leclerc J; Guilmeau S; Huet C; Charifi W; Varin TV; Daniel N; Foretz M; Neunlist M; Salomon BL; Ghosh P; Marette A; Rolli-Derkinderen M; Viollet B
Mol Metab; 2021 May; 47():101183. PubMed ID: 33548500
[TBL] [Abstract][Full Text] [Related]
9. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
Bang S; Chen Y; Ahima RS; Kim SF
Mol Endocrinol; 2014 Jul; 28(7):1186-93. PubMed ID: 24877601
[TBL] [Abstract][Full Text] [Related]
10. Metformin stimulates FGF21 expression in primary hepatocytes.
Nygaard EB; Vienberg SG; Ørskov C; Hansen HS; Andersen B
Exp Diabetes Res; 2012; 2012():465282. PubMed ID: 23118742
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of metformin glycinate and hydrochloride in glucose production, AMPK phosphorylation and insulin sensitivity in hepatocytes from non-diabetic and diabetic mice.
Rada P; Mosquera A; Muntané J; Ferrandiz F; Rodriguez-Mañas L; de Pablo F; González-Canudas J; Valverde ÁM
Food Chem Toxicol; 2019 Jan; 123():470-480. PubMed ID: 30414960
[TBL] [Abstract][Full Text] [Related]
12. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).
Cao J; Meng S; Chang E; Beckwith-Fickas K; Xiong L; Cole RN; Radovick S; Wondisford FE; He L
J Biol Chem; 2014 Jul; 289(30):20435-46. PubMed ID: 24928508
[TBL] [Abstract][Full Text] [Related]
13. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity.
Ford RJ; Fullerton MD; Pinkosky SL; Day EA; Scott JW; Oakhill JS; Bujak AL; Smith BK; Crane JD; Blümer RM; Marcinko K; Kemp BE; Gerstein HC; Steinberg GR
Biochem J; 2015 May; 468(1):125-32. PubMed ID: 25742316
[TBL] [Abstract][Full Text] [Related]
14. Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice.
Fujita Y; Hosokawa M; Fujimoto S; Mukai E; Abudukadier A; Obara A; Ogura M; Nakamura Y; Toyoda K; Nagashima K; Seino Y; Inagaki N
Diabetologia; 2010 Jul; 53(7):1472-81. PubMed ID: 20349346
[TBL] [Abstract][Full Text] [Related]
15. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.
Miller RA; Chu Q; Xie J; Foretz M; Viollet B; Birnbaum MJ
Nature; 2013 Feb; 494(7436):256-60. PubMed ID: 23292513
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase in the grass carp Ctenopharyngodon idellus: Molecular characterization, tissue distribution and mRNA expression in response to overwinter starvation stress.
Wu W; Sun J; Ji H; Yu H; Zhou J
Comp Biochem Physiol B Biochem Mol Biol; 2020; 246-247():110457. PubMed ID: 32417494
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
18. An energetic tale of AMPK-independent effects of metformin.
Miller RA; Birnbaum MJ
J Clin Invest; 2010 Jul; 120(7):2267-70. PubMed ID: 20577046
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells.
Zang M; Zuccollo A; Hou X; Nagata D; Walsh K; Herscovitz H; Brecher P; Ruderman NB; Cohen RA
J Biol Chem; 2004 Nov; 279(46):47898-905. PubMed ID: 15371448
[TBL] [Abstract][Full Text] [Related]
20. Metformin: from mechanisms of action to therapies.
Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
